🔎 Trials Near Me

Почетна › Затајење срца › Тексас › Houston

Kliničke studije za Затајење срца u gradu Houston, TX

35 studija za Затајење срца traži učesnike na lokacijama u gradu Houston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

Тражи се учесникФаза 2/3
  • Texas Children's Hospital ( Site 0039), Houston
29 Days – 17 Years · Оба пола · Ажурирано 13. 11. 2026. · NCT05714085

Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure

Тражи се учесник
  • Baylor College of Medicine, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT06552637

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Тражи се учесникФаза 3
  • The Methodist Hospital Research Institute, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06935370

Left vs Left Randomized Clinical Trial

Тражи се учесник
  • Baylor College of Medicine, Houston
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT05650658

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Тражи се учесник
  • CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
  • Houston Methodist, Houston
  • UTHealth Memorial Hermann, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06526195

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Тражи се учесникОпсервациона студија
  • Houston, Houston
Сви узрасти · Оба пола · Ажурирано 4. 11. 2026. · NCT00271180

A Study of LY3971297 in Participants With Heart Failure

Тражи се учесникФаза 1
  • Houston Methodist Hospital, Houston
Узраст од 18 до 65 · Оба пола · Ажурирано 4. 11. 2026. · NCT07547540

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Тражи се учесникФаза 3
  • CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT06736574

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Тражи се учесникФаза 3
  • East Texas Cardiology PA, Houston
  • Biopharma Informatic, Houston
  • Orion Medical, Houston
  • и још 3
Узраст од 18 до 99 · Оба пола · Ажурирано 29. 10. 2026. · NCT07037459

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Тражи се учесникФаза 3
  • Texas Children's Hospital - Cardiology, Houston
До 18 година · Оба пола · Ажурирано 27. 10. 2026. · NCT07192952

Cardiogenic Shock Working Group Registry

Тражи се учесникОпсервациона студија
  • Houston Methodist Hospital, Houston
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT04682483

Assessment of CCM in HF With Higher Ejection Fraction

Тражи се учесник
  • Baylor College of Medicine, Houston
  • Houston Methodist, Houston
  • Memorial Hermann Texas Medical Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT05064709

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Тражи се учесникФаза 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Houston
  • и још 2
Узраст 40 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06677060

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

Тражи се учесникФаза 3
  • Texas Children's Hospital - Cardiology, Houston
6 Months – 17 Years · Оба пола · Ажурирано 15. 10. 2026. · NCT07188805

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

Тражи се учесникФаза 2
  • Local Institution - 19, Houston
  • Local Institution - 20, Houston
  • Local Institution - 21, Houston
Узраст од 30 до 84 · Оба пола · Ажурирано 13. 10. 2026. · NCT07795814

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Тражи се учесникФаза 3
  • Research Site, Houston
Узраст од 18 до 130 · Оба пола · Ажурирано 13. 10. 2026. · NCT06307652

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)

Тражи се учесник
  • Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Узраст 60 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT05996328

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

Тражи се учесникФаза 2
  • East Texas Cardiology PA, Houston
Узраст од 40 до 84 · Оба пола · Ажурирано 5. 10. 2026. · NCT06979362

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

Тражи се учесникФаза 3
  • Research Site, Houston
  • Research Site, Houston
  • Research Site, Humble · 17 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07761117

BiVACOR® Total Artificial Heart Early Feasibility Study

Тражи се учесник
  • Texas Heart Institute / Baylor St. Luke's Medical Center, Houston
Узраст од 18 до 70 · Оба пола · Ажурирано 28. 9. 2026. · NCT06174103

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Тражи се учесникФаза 3
  • CON-10085, Houston, TX, Houston
  • Houston, TX Investigative Site CON-10320, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06024746

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Тражи се учесникФаза 3
  • Houston, TX Investigative Site 10085, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT06008197

Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

Тражи се учесникОпсервациона студија
  • Methodist DeBakey Heart and Vascular Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT07436299

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Тражи се учесникФаза 2
  • Center for Advanced Heart Failure, Houston
Узраст од 40 до 85 · Оба пола · Ажурирано 27. 8. 2026. · NCT06793371

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

Тражи се учесникОпсервациона студија
  • Texas Children's Hospital, Houston
До 18 година · Оба пола · Ажурирано 25. 8. 2026. · NCT06532890

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Тражи се учесник
  • Texas Heart Institute, Houston
Узраст 21 и старији · Оба пола · Ажурирано 25. 8. 2026. · NCT05677100

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

Тражи се учесникОпсервациона студија
  • The Methodist Hospital, Methodist Cancer Cencer, Houston
  • BI Research Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 19. 8. 2026. · NCT05489705

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Тражи се учесникФаза 3
  • East Texas Cardiology PA, Houston
  • Victorium Clinical Research, Houston
  • Main Heart Clinic, Houston
  • и још 1
Узраст 18 и старији · Оба пола · Ажурирано 18. 8. 2026. · NCT07567001

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

Тражи се учесникФаза 3
  • FIN-10085, Houston, TX, Houston
Узраст 18 и старији · Оба пола · Ажурирано 10. 7. 2026. · NCT06033950

18F-mFBG Imaging for Myocardial Sympathetic Innervation

Тражи се учесникФаза 2
  • UT Health Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT06965621

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

Тражи се учесник
  • Baylor/Texas Heart, Houston
Узраст 18 и старији · Оба пола · Ажурирано 29. 6. 2026. · NCT05934487

Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)

Тражи се учесникОпсервациона студија
  • Baylor College of Medicine, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 5. 2026. · NCT06641362

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Тражи се учесник
  • Houston Healthcare Medical Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 13. 4. 2026. · NCT03142152

Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure

Тражи се учесникФаза 1
  • Texas Heart Institute, Houston
Узраст од 18 до 79 · Оба пола · Ажурирано 27. 4. 2025. · NCT06831825

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Тражи се учесникОпсервациона студија
  • Houston Methodist DeBakey Heart and Vascular Center, Houston
Узраст од 18 до 100 · Оба пола · Ажурирано 22. 5. 2024. · NCT06425848

Studije za Затајење срца u drugim gradovima

Ostale studije u gradu Houston

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.